Curaleaf Holdings, Inc. balance sheet CURLF

Annual Quarterly

As of Sep 30, 2026, Curaleaf Holdings, Inc. had total assets of $2.8 billion and total liabilities of $1.9 billion. Stockholders' equity was $847.0 million. It held $92.4 million in cash and investments against $928.5 million of total debt, net debt of $836.1 million. The current ratio, current assets divided by current liabilities, was 1.61.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

Line	FY 2026 Sep 30, 2026	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Assets
Cash	92	102 -5.3%	107 +16.8%	92 -43.7%	163 -45.5%	299 +307.0%	74
Long-term investments	—	—	—	2 -11.4%	3	—	—
Cash and investments	92	102 -5.3%	107 +13.7%	94 -43.2%	166 -44.6%	299 +307.0%	74
Receivables	77	74 +15.4%	64 +6.7%	60 +32.8%	45	—	—
Inventory	240	225 +3.7%	217 +0.5%	216 -8.0%	235	—	—
Total current assets	464	449 +3.3%	434 +3.8%	419 -35.8%	652	—	—
Property and equipment, net	501	520 -4.1%	543 -5.1%	572 -4.1%	596	—	—
Goodwill	638	635 +1.0%	629 +0.4%	627 +0.2%	625 +9.4%	572 +6.0%	539
Total assets	2,793	2,845 -3.5%	2,950 -4.7%	3,097 -9.3%	3,415 +10.0%	3,105 +31.3%	2,366
Liabilities and equity
Accounts payable	64	75 -5.6%	79 -0.2%	79 -1.8%	81	—	—
Total current liabilities	288	294 -24.1%	388 -21.5%	494 -0.6%	497	—	—
Total liabilities	1,946	2,005 +2.5%	1,956 +1.6%	1,925 -4.4%	2,014 +39.8%	1,440 +46.2%	985
Stockholders' equity	847	756 -12.2%	861 -18.0%	1,051 -17.9%	1,280	—	—
Debt
Debt due within a year	46	36 -64.9%	102 +157.7%	39 -23.9%	52 -88.1%	436 +49.6%	292
Long-term debt	583	513 +9.9%	467 -14.8%	548 -3.9%	571	—	—
Lease liabilities	299	278 -2.4%	285 -3.6%	296 -3.4%	306 -4.2%	319 +10.6%	289
Total debt	928	827 -3.1%	854 -3.4%	884 -4.9%	929 +22.9%	756 +30.2%	580
Net cash	-836	-725 +2.8%	-747 +5.4%	-789 -3.5%	-763 -67.2%	-456 +10.0%	-507
Ratios
Current ratio	1.61x	1.52x	1.12x	0.85x	1.31x	—	—
Debt to equity	1.10x	1.09x	0.99x	0.84x	0.73x	—	—
Debt to EBITDA	—	3.72x	3.33x	3.70x	4.20x	—	—
Return on equity	—	-30.55%	-25.01%	-26.76%	-28.92%	—	—
Return on assets	—	-8.12%	-7.30%	-9.08%	-10.84%	—	—
Book value per share	3.20	—	1.15	1.43	—	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. The first column is the latest balance sheet when it is newer than the latest fiscal year. More on our methodology.

Company profile

Industry: Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as: CURLF (OTC)
Fiscal year ends: December 31
Incorporated in: British Columbia, Canada
Headquarters: Stamford, CT
SEC filer status: Large accelerated filer
SEC CIK: 1756770

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.